Building a Growth Roadmap for Topical Pain Relief

We helped a leading OTC pain-relief brand identify unmet consumer needs, develop new product opportunities, and build a five-year innovation roadmap for growth.

I led the engagement across opportunity discovery, concept development, validation, and portfolio prioritization, aligning consumer insight, design, marketing, and R&D around a shared view of where the category could grow.

The resulting roadmap guided development of new offerings that generated more than $20 million in incremental sales.

Project Info

Client: A Leading Pharmaceutical Manufacturer

Time: 2017, 9 Months

Role: Project Lead, Strategist, Principal Investigator

Project Overview

Key Takeaways

Finding Common Needs Across Different Experiences

Pain is highly personal, and the consumers represented a wide range of chronic conditions, temporary injuries, lifestyles, and treatment behaviors.

The strategic challenge was not to collapse those differences, but to identify the deeper needs that connected them.

Doing so allowed us to define opportunity spaces broad enough to support category-level investment while remaining grounded in meaningful differences between consumers.

Expanding the Role of OTC Pain Relief

For consumers managing chronic pain, OTC products often acted as a manageable first line of defense that offered greater control over how and when pain was treated.

For more active consumers, we saw a different opportunity: managing discomfort without having to step away from work, exercise, or everyday life.

Together, those patterns broadened the organization’s view of the role topical pain relief could play and where differentiated offerings could create value.

Challenges

Turning Diverse Needs into Portfolio Direction

The breadth of the category created a strategic challenge in determining which needs belonged to specific pain experiences and which could justify broader investment.

I guided the team in maintaining the richness of individual experiences while identifying patterns strong enough to inform decisions at the category and portfolio level.

That synthesis was essential to moving from consumer evidence toward a manageable innovation roadmap.

Leading Through a Sensitive Subject

Many participants had lived with chronic pain for years, creating an emotionally demanding environment for both participants and the project team.

As engagement lead, I made space for the team to process difficult encounters while maintaining momentum, quality, and focus.

Supporting the team in that way helped ensure empathy remained a source of strategic understanding rather than simply an artifact of the research process.